One month on from the start of Russia’s invasion of Ukraine on 24 February, relief efforts are progressing across the off-patent industry as the conflict continues.
Regional generics and biosimilars association Medicines for Europe has highlighted that the supply of medicines is “critical yet unstable as war continues in Ukraine,” urging “special effort and protection” from European heads of state and governments,